Effects of sodium–glucose cotransporter 2 inhibitors on non‐alcoholic fatty liver disease in patients with type 2 diabetes: A meta‐analysis of randomized controlled trialsBaodi Xing, Wenjuan Zhao, Yuhang Zhao et al.|Journal of Diabetes Investigation|2020Cited by 76